Sign in
4

Changes in Ownership

Beam Therapeutics Inc. Filed Acc 0000899243-21-000136

CEO sold 22,300 shares at an average $84.94 ($1,894,125)

From the SEC's structured data for this filing

Trades in this filing

Evans John M. · CEO

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-30 Sale : show line 1 in the form −1,366 $81.14 $110,837 991,891 D
2020-12-30 Sale : show line 2 in the form −4,100 $82.33 $337,553 987,791 D
2020-12-30 Sale : show line 3 in the form −4,925 $83.76 $412,518 982,866 D
2020-12-30 Sale : show line 4 in the form −1,422 $85.35 $121,368 981,444 D
2020-12-30 Sale : show line 5 in the form −7,196 $86.21 $620,367 974,248 D
2020-12-30 Sale : show line 6 in the form −504 $86.79 $43,742 973,744 D
2020-12-30 Sale : show line 7 in the form −1,121 $88.12 $98,783 972,623 D
2020-12-30 Sale : show line 8 in the form −1,666 $89.41 $148,957 970,957 D
Open-market sales · 22,300 sh · avg $84.94 · $1,894,125
Loading xslF345X03/doc4.xml…